Delivery Order SPE2DB22D9143-SPE2DB24FZB42
Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, with a period of performance through August 12, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order worth $25,868.10 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for 120 capsules of the pharmaceutical product XTANDI 40 MG and has a completion date of February 7, 2024. This order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025, which enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,321.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 1, 2022, is for the supply of 4557937756 - XTANDI 40 MG CAPSULE 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which runs...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,311.35 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, with a period of performance through March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $34,490.80. The order calls for the delivery of 4562939401 XTANDI 40 MG CAPSULE 120S to Park Ridge, Illinois by November 30, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical products with a potential value of up to $5 million through...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 5, 2024, is for the delivery of XTANDI 80 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $4,311.35 by the Defense Logistics Agency to supply 120 capsules of XTANDI 40 MG CAPSULE. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide XTANDI 40 MG CAPSULE 120S. The $12,934.05 order has a completion date of December 5, 2023 and was awarded on December 4, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $4,169.59, is for the delivery of XTANDI 40 MG TABLET 120S, with an ultimate completion date of April 5, 2024. This award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at...